Catalyst Wire Dossier Catalyst Wire Dossier

XELJANZ XR

tofacitinib · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for XELJANZ XR, covering 2016-02-23 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Korean Post-marketing Surveillance for Xeljanz XR

See pricing